NTRA Q1 2020 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q1 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$94M+40.7% YoY

Gross Profit

$49M52.2% margin

Operating Income

-$35M-37.1% margin

Net Income

-$35M-37.6% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

+12.9%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$43M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$559M

Total Liabilities

$300M

Stockholders' Equity

$259M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$67M	+40.7%
Gross Profit	$49M	$24M	+108.5%
Operating Income	-$35M	-$32M	-9.8%
Net Income	-$35M	-$34M	-3.8%

Revenue Segments

Product

$87M86%

Licensing And Other

$7M7%

License And Development Services

$5M5%

Upfront License And Constellation And Paternity Services

$1M1%

Other Licensing And Other

$797,0001%

Geographic Segments

U

$87M92%

E M E A

$3M4%

Other Geographic Areas

$3M3%

Americas Excluding Us

$782,0001%